InvestorsHub Logo
Followers 14
Posts 2874
Boards Moderated 0
Alias Born 12/23/2014

Re: budge post# 2421

Sunday, 09/15/2019 12:57:42 PM

Sunday, September 15, 2019 12:57:42 PM

Post# of 2463
@Budge - What you say for HALO increasing REPR's TAM is true for all pharma reformulating existing drugs for SubQ. The cost advantages and conveniences of home, self administered SubQ infusions is creating a paradigm shift in drug administration. REPR is well positioned to ride this wave!!